Multiple sclerosis, interferon beta-1b and depression A prospective investigation.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12140662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute and maintenance treatment of chronic depression.

  2001cited by this paper
• Multiple sclerosis, disease modifying treatments and depression: a critical methodological review

  2000cited by this paper
• Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial.

  1999cited by this paper
• Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.

  1999cited by this paper
• Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b

  1999cited by this paper
• Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

  1998cited by this paper
• Multiple sclerosis, depression, and suicide

  1997cited by this paper
• Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.

  1997cited by this paper
• Management of patients receiving interferon beta-1b for multiple sclerosis

  1996cited by this paper
• Side effect profile of interferon beta-1b in MS: results of an open label trial.

  1996cited by this paper
• Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

  1995cited by this paper
• Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.

  1995cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• The Effect of Fluoxetine in Depression Associated with Multiple Sclerosis

  1992cited by this paper
• Effect of fluoxetine on patients with multiple sclerosis.

  1991cited by this paper
• Antidepressant pharmacotherapy of depression associated with multiple sclerosis.

  1990cited by this paper
• Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis

  1988cited by this paper
• Depression in multiple sclerosis.

  1987cited by this paper
• Personal and family history of affective illness in patients with multiple sclerosis.

  1987cited by this paper
• Longitudinal data analysis for discrete and continuous outcomes.

  1986cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper

• Unraveling the Pathogenesis of Post‐Stroke Depression in a Hemorrhagic Mouse Model through Frontal Lobe Circuitry and JAK‐STAT Signaling

  2024cites this paper
• A Grave Set of Diagnoses: A Case of Mania with Comorbid Autoimmune Thyroiditis Precipitated by Multiple Sclerosis Treatment.

  2023cites this paper
• Sensory-Motor and Affective-Fatigue Factors are Associated with Symbol Digit Performance in Multiple Sclerosis

  2021cites this paper
• Risk of depression in multiple sclerosis across disease-modifying therapies

  2021cites this paper
• Predictors of hospitalization in a Canadian MS population: A matched cohort study.

  2020cites this paper
• Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

  2020cites this paper
• COVID-19, interferons, and depression: A commentary.

  2020cites this paper
• Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients

  2020cites this paper
• Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis.

  2020cites this paper
• Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options

  2019cites this paper
• Psychopharmacology of multiple sclerosis.

  2019cites this paper
• “After the transition is before the transition” – Experiences of medically induced treatment discontinuation of disease-modifying therapies in people with multiple sclerosis: A qualitative descriptive study.

  2019cites this paper
• Psychiatric disorders in multiple sclerosis

  2019cites this paper
• Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation : nationwide epidemiological studies on etiology, comorbidities, and treatment

  2019cites this paper
• Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations

  2019cites this paper
• Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 1.

  2019cites this paper
• Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study.

  2018cites this paper
• Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome

  2018cites this paper
• Multiple sclerosis and suicide

  2017cites this paper
• Neuropsychiatric syndromes of multiple sclerosis

  2017cites this paper
• Depression in multiple sclerosis

  2017cites this paper
• Antidepressant Drug Treatment in Association with Multiple Sclerosis Disease-Modifying Therapy: Using Explorys in the MS Population.

  2016cites this paper
• Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder

  2016cites this paper
• Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception

  2016cites this paper
• DEPRESSION IN MULTIPLE SCLEROSIS – REVIEW

  2015cites this paper
• Alterations in Gene Expression in Depression: Prospects for Personalize Patient Treatment.

  2015cites this paper
• The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

  2015cites this paper
• Correlation between Expanded Disability Status Scale , Depression , Quality of Life and Age in Patients with Multiple Sclerosis

  2015cites this paper
• Progressive multiple sclerosis and mood disorders

  2015cites this paper
• Neurobehavioral burden of multiple sclerosis with nanotheranostics

  2015cites this paper
• Symptomatic treatment and management of multiple sclerosis.

  2014cites this paper
• The link between multiple sclerosis and depression

  2014cites this paper
• [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

  2014cites this paper
• Cytokines as biomarkers in depressive disorder: Current standing and prospects

  2013cites this paper
• Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations

  2012cites this paper
• Depression levels and interferon treatment in people with multiple sclerosis.

  2012cites this paper
• [Depression and neurological diseases].

  2012cites this paper
• Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis.

  2012cites this paper
• Presentation and Validation of the Multiple Sclerosis Depression Rating Scale: A Test Specifically Devised to Investigate Affective Disorders in Multiple Sclerosis Patients

  2012cites this paper
• Biological outcome measurements for behavioral interventions in multiple sclerosis

  2011cites this paper
• Multiple sclerosis and depression

  2011cites this paper
• Drug-Induced Diseases: Depression

  2011cites this paper
• Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.

  2011cites this paper
• Pathogenic mechanisms of depression in multiple sclerosis.

  2011cites this paper
• Positive everyday experiences interact with social support to predict depression in multiple sclerosis

  2010cites this paper
• Severe Depression, Suicide Attempts, and Ideation During the Use of Interferon Beta by Patients With Multiple Sclerosis

  2010cites this paper
• A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events

  2009cites this paper
• Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

  2009cites this paper
• Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.

  2009cites this paper
• A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events.

  2009cites this paper
• Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment

  2009cites this paper
• [Depression in multiple sclerosis].

  2009cites this paper
• Depression in multiple sclerosis: Review and theoretical proposal

  2008cites this paper
• Longitudinal Study of the Symptom Checklist 90-Revised in Multiple Sclerosis Patients

  2008cites this paper
• Psychological aspects of multiple sclerosis.

  2008cites this paper
• Diagnosis and Management

  2008cites this paper
• Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis

  2008cites this paper
• The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.

  2007cites this paper
• Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression

  2007cites this paper
• Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample

  2007cites this paper
• Aspectos neuropsiquiátricos de la enfermedad de Wilson y la esclerosis múltiple

  2007cites this paper
• Recognizing and Treating Common Psychiatric Disorders in Multiple Sclerosis

  2007influential citation
• Psychiatric issues in multiple sclerosis.

  2007cites this paper
• The neuropsychiatry of multiple sclerosis: a review of recent developments

  2007cites this paper
• Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder

  2007cites this paper
• Multiple sclerosis and behavior.

  2007cites this paper
• Multiple Sclerosis and Demyelinating Diseases

  2007cites this paper
• The safety and efficacy of IFN-β products for the treatment of multiple sclerosis

  2007cites this paper
• Longitudinal course of depression symptoms in multiple sclerosis

  2006cites this paper
• Psychiatric side effects of interferon-β in multiple sclerosis

  2006cites this paper
• Psychiatric side effects of interferon-beta in multiple sclerosis.

  2006cites this paper
• The neuropsychiatry of multiple sclerosis

  2006cites this paper
• Psychiatric side effects of interferon treatment.

  2006cites this paper
• Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

  2006cites this paper
• Long-term emotional state of multiple sclerosis patients treated with interferon beta

  2006cites this paper
• Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy

  2005cites this paper
• Update on depression in neurologic illness: Stroke, epilepsy, and multiple sclerosis

  2005cites this paper
• Depression in older patients with neurologic illness: causes, recognition, management.

  2005cites this paper
• Depression in multiple sclerosis: a review

  2005cites this paper
• The Goldman Consensus statement on depression in multiple sclerosis

  2005cites this paper
• Störungen von Affekt und Kognition bei Patienten mit Multipler Sklerose

  2004cites this paper
• Drug-Induced Depression: A Systematic Review to Inform Clinical Practice

  2004cites this paper
• QUINTEssentials®

  2004cites this paper
• The Neuropsychiatry of Multiple Sclerosis

  2004cites this paper
• The phenomenology and treatment of interferon-induced depression.

  2004cites this paper
• Management of multiple sclerosis: current trials and future options.

  2003cites this paper
• Multiple sclerosis and depression: influence of interferon beta therapy.

  2003cites this paper
• Optic neuritis in multiple sclerosis

  2002cites this paper